中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月17日星期四
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2020, Vol. 27 Issue (27): 102-105    
  妇幼医学 本期目录 | 过刊浏览 | 高级检索 |
阿奇霉素联合金刚藤胶囊及保妇康栓治疗沙眼衣原体阴道宫颈炎的临床效果
王丹妮1 刘宪鸣2
1.福建医科大学附属泉州市第一医院皮肤科,福建泉州 362000;
2.福建医科大学附属泉州市第一医院中医妇科,福建泉州 362000
Clinical effect of Azithromycin combined with Jingangteng Capsules and Baofukang Suppository in the treatment of Chlamydia trachomatis vagina cervicitis
WANG Dan-ni1 LIU Xian-ming2#br#
1. Department of Dermatology, Quanzhou First Affiliated Hospital of Fujian Medical University, Fujian Province,Quanzhou 362000, China; 
2. Department of Gynecology of Traditional Chinese Medicine, Quanzhou First Affiliated Hospital of Fujian Medical University, Fujian Province, Quanzhou 362000, China
全文: PDF (0 KB)   HTML (34 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 
目的 探讨阿奇霉素联合金刚藤胶囊及保妇康栓治疗沙眼衣原体阴道宫颈炎的临床效果。方法 选取2013年1月~2018年11月我院皮肤科及中医妇科门诊收治的272 例沙眼衣原体阴道宫颈感染患者作为研究对象,采取随机双盲法分为治疗组(157 例)与对照组(115 例)。治疗组患者给予阿奇霉素片、金刚藤胶囊口服,并予保妇康栓阴道纳药,对照组患者单用阿奇霉素片。连续用药2 周,停药1 周后复查,比较两组患者的疗效、治疗后症状体征变化情况及症状评分。结果 治疗组的总有效率(86.6%)高于对照组的72.2%,差异有统计学意义(P<0.01)。治疗组在病原体、分泌物增多、清洁度异常等症状体征方面的改善情况均优于对照组,差异有统计学意义(P<0.05)。治疗组治疗后的症状评分低于对照组,差异有统计学意义(P<0.05)。结论 阿奇霉素联合金刚藤胶囊及保妇康栓治疗沙眼衣原体阴道宫颈炎的效果优于单用阿奇霉素,可作为临床上治疗沙眼衣原体阴道宫颈炎的应用方案。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 沙眼衣原体阿奇霉素金刚藤胶囊保妇康栓    
Abstract
Objective To investigate the clinical effect of Azithromycin combined with Jingangteng Capsules and Baofukang Suppository in the treatment of Chlamydia trachomatis vagina cervicitis. Methods A total of 272 patients with Chlamydia trachomatis vagina cervicitis treated in departmemt of dermatology and gynecology clinic of traditional Chinese medicine of our hospital from January 2013 to November 2018 were selected as the research subjects and divided into the treatment group (157 cases) and the control group (115 cases) by randomized and double-blind method. The treatment group was given Azithromycin Tablets and Jingangteng Capsules for oral administration, and Baofukang Suppository was given to the vagina. The control group was given Azithromycin Tablets alone. The drug was administered continuously for 2 weeks and rechecked 1 week after the drug was stopped. The efficacy, changes in symptoms and signs, symptom score were compared between the two groups. Results The total effective rate in the treatment group(86.6%) was higher than that in the control group (72.2%), and the difference was statistically significant (P<0.01). The improvement of symptoms and signs, such as pathogen, increased secretion, and abnormal cleanliness in the treatment group were superior than those in the control group, and the differences were statistically significant (P<0.05). The symptom score of the treatment group was lower than that of the control group, and the difference was statistically significant (P<0.05). Conclusion The therapeutic effect of Azithromycin combined with Jingangteng Capsules and Baofukang Suppositoryon in the treatment of Chlamydia trachomatis vaginal cervicitis is better than that of Azithromycin alone and can be used as a clinical treatment for Chlamydia trachomatis vaginal cervicitis.
Key wordsChlamydia trachomatis    Azithromycin    Jingangteng Capsules    Baofukang Suppository
    
引用本文:   
王丹妮; 刘宪鸣. 阿奇霉素联合金刚藤胶囊及保妇康栓治疗沙眼衣原体阴道宫颈炎的临床效果[J]. 中国当代医药, 2020, 27(27): 102-105.
WANG Dan-ni1 LIU Xian-ming2. Clinical effect of Azithromycin combined with Jingangteng Capsules and Baofukang Suppository in the treatment of Chlamydia trachomatis vagina cervicitis. 中国当代医药, 2020, 27(27): 102-105.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2020/V27/I27/102
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载